Literature DB >> 20610682

Does a feline leukemia virus infection pave the way for Bartonella henselae infection in cats?

Alexandra U Buchmann1, Olivia Kershaw, Volkhard A J Kempf, Achim D Gruber.   

Abstract

Domestic cats serve as the reservoir hosts of Bartonella henselae and may develop mild clinical symptoms or none after experimental infection. In humans, B. henselae infection can result in self-limiting cat scratch disease. However, immunocompromised patients may suffer from more-severe courses of infection or may even develop the potentially lethal disease bacillary angiomatosis. It was reasoned that cats with immunocompromising viral infections may react similarly to B. henselae infection. The aim of our study was to investigate the influence of the most important viruses known to cause immunosuppression in cats-Feline leukemia virus (FeLV), Feline immunodeficiency virus (FIV), and Feline panleukopenia virus (FPV)-on natural B. henselae infection in cats. Accordingly, 142 cats from animal shelters were necropsied and tested for B. henselae and concurrent infections with FeLV, FIV, or FPV by PCR and immunohistochemistry. A significant association was found between B. henselae and FeLV infections (P = 0.00028), but not between B. henselae and FIV (P = 1.0) or FPV (P = 0.756) infection, age (P = 0.392), or gender (P = 0.126). The results suggest that susceptibility to B. henselae infection is higher in cats with concurrent FeLV infections, regardless of whether the infection is latent or progressive. Histopathology and immunohistochemistry for B. henselae failed to identify lesions that could be attributed specifically to B. henselae infection. We conclude that the course of natural B. henselae infection in cats does not seem to be influenced by immunosuppressive viral infections in general but that latent FeLV infection may predispose cats to B. henselae infection or persistence.

Entities:  

Mesh:

Year:  2010        PMID: 20610682      PMCID: PMC2937684          DOI: 10.1128/JCM.00750-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Bartonella spp antibodies and DNA in aqueous humour of cats.

Authors:  M R Lappin; D L Kordick; E B Breitschwerdt
Journal:  J Feline Med Surg       Date:  2000-03       Impact factor: 2.015

2.  Does coinfection of Bartonella henselae and FIV induce clinical disorders in cats?

Authors:  H Ueno; T Hohdatsu; Y Muramatsu; H Koyama; C Morita
Journal:  Microbiol Immunol       Date:  1996       Impact factor: 1.955

Review 3.  The influence of human immunodeficiency virus-1 on hematopoiesis.

Authors:  A Moses; J Nelson; G C Bagby
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

4.  Re-examination of feline leukemia virus: host relationships using real-time PCR.

Authors:  Andrea N Torres; Candace K Mathiason; Edward A Hoover
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

5.  Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.

Authors:  R Hofmann-Lehmann; E Holznagel; P Ossent; H Lutz
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

6.  Immunohistochemical study of lymph nodes in patients with cat scratch disease.

Authors:  Ying-You Lin; Cheng-Hsiang Hsiao; Yung-Hsiang Hsu; Chin-Cheng Lee; Hsiang-Jung Tsai; Ming-Jeng Pan
Journal:  J Formos Med Assoc       Date:  2006-11       Impact factor: 3.282

7.  Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis.

Authors:  L N Slater; D F Welch; K W Min
Journal:  Arch Intern Med       Date:  1992-03

8.  Hematopoiesis in asymptomatic cats infected with feline immunodeficiency virus.

Authors:  M L Linenberger; G H Shelton; M T Persik; J L Abkowitz
Journal:  Blood       Date:  1991-10-15       Impact factor: 22.113

9.  [Epidemiology of FeLV and FIV infection in the Federal Republic of Germany].

Authors:  A Fuchs; L Binzel; M Lonsdorfer
Journal:  Tierarztl Prax       Date:  1994-06

10.  Bartonella henselae invasion of feline erythrocytes in vitro.

Authors:  J R Mehock; C E Greene; F C Gherardini; T W Hahn; D C Krause
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more
  7 in total

Review 1.  Intruders below the radar: molecular pathogenesis of Bartonella spp.

Authors:  Alexander Harms; Christoph Dehio
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

2.  Molecular survey of Bartonella henselae and Bartonella clarridgeiae in pet cats across Japan by species-specific nested-PCR.

Authors:  S Sato; H Kabeya; A Negishi; H Tsujimoto; K Nishigaki; Y Endo; S Maruyama
Journal:  Epidemiol Infect       Date:  2017-08-07       Impact factor: 4.434

3.  Differential effects of Bartonella henselae on human and feline macro- and micro-vascular endothelial cells.

Authors:  Moez Berrich; Claudine Kieda; Catherine Grillon; Martine Monteil; Nathalie Lamerant; Julie Gavard; Henri Jean Boulouis; Nadia Haddad
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

4.  Three pathogens in sympatric populations of pumas, bobcats, and domestic cats: implications for infectious disease transmission.

Authors:  Sarah N Bevins; Scott Carver; Erin E Boydston; Lisa M Lyren; Mat Alldredge; Kenneth A Logan; Seth P D Riley; Robert N Fisher; T Winston Vickers; Walter Boyce; Mo Salman; Michael R Lappin; Kevin R Crooks; Sue VandeWoude
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

5.  Uterine adenocarcinoma with feline leukemia virus infection.

Authors:  Sung-Jin Cho; Hyun-A Lee; Sunhwa Hong; Okjin Kim
Journal:  Lab Anim Res       Date:  2011-12-19

Review 6.  Bartonella infections in cats and dogs including zoonotic aspects.

Authors:  Alejandra Álvarez-Fernández; Edward B Breitschwerdt; Laia Solano-Gallego
Journal:  Parasit Vectors       Date:  2018-12-04       Impact factor: 3.876

7.  Population structure of Bartonella henselae in Algerian urban stray cats.

Authors:  Naouelle Azzag; Nadia Haddad; Benoit Durand; Elisabeth Petit; Ali Ammouche; Bruno Chomel; Henri-Jean Boulouis
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.